Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

SRRK

Scholar Rock (SRRK)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRRK
DataOraFonteTitoloSimboloCompagnia
03/06/202422:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRRKScholar Rock Holdings Corporation
03/06/202422:00Business WireScholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
28/05/202414:00Business WireScholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
22/05/202413:00Business WireScholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in ObesityNASDAQ:SRRKScholar Rock Holdings Corporation
20/05/202414:00Business WireScholar Rock to Participate in Upcoming Investor ConferencesNASDAQ:SRRKScholar Rock Holdings Corporation
17/05/202422:15Business WireScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SRRKScholar Rock Holdings Corporation
14/05/202414:00Business WireScholar Rock to Host Investor Day on May 22, 2024NASDAQ:SRRKScholar Rock Holdings Corporation
07/05/202413:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRRKScholar Rock Holdings Corporation
07/05/202413:00Business WireScholar Rock Reports First Quarter 2024 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
19/03/202412:00Business WireScholar Rock Reports Full Year 2023 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
20/02/202422:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
15/02/202422:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
15/02/202414:00Business WireScholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific OfficerNASDAQ:SRRKScholar Rock Holdings Corporation
06/02/202414:00Business WireScholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss ManagementNASDAQ:SRRKScholar Rock Holdings Corporation
23/01/202415:02Dow Jones NewsScholar Rock Says FDA Clears Application for Trial of Obesity Treatment ApitegromabNASDAQ:SRRKScholar Rock Holdings Corporation
23/01/202414:00Business WireScholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat ObesityNASDAQ:SRRKScholar Rock Holdings Corporation
04/01/202414:00Business WireScholar Rock Provides Corporate Update and Highlights Priorities for 2024NASDAQ:SRRKScholar Rock Holdings Corporation
19/12/202314:00Business WireScholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SRRKScholar Rock Holdings Corporation
15/12/202300:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
07/11/202313:15Business WireScholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
03/11/202321:00Business WireScholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued TolerabilityNASDAQ:SRRKScholar Rock Holdings Corporation
19/10/202314:00Business WireScholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
16/10/202322:15Business WireScholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional SharesNASDAQ:SRRKScholar Rock Holdings Corporation
12/10/202322:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SRRKScholar Rock Holdings Corporation
12/10/202302:57Business WireScholar Rock Announces Pricing of Upsized Public Offering of Common StockNASDAQ:SRRKScholar Rock Holdings Corporation
11/10/202323:05Business WireScholar Rock Announces Proposed Public Offering of Common StockNASDAQ:SRRKScholar Rock Holdings Corporation
11/10/202322:44Business WireScholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic DisordersNASDAQ:SRRKScholar Rock Holdings Corporation
19/09/202314:00Business WireScholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE TrialNASDAQ:SRRKScholar Rock Holdings Corporation
09/08/202322:15Business WireScholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
30/06/202317:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRKScholar Rock Holdings Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRRK

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network